Journal of Clinical Epidemiology
Volume 64, Issue 3 , Pages 293-300 , March 2011

Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials

  • David D. Rahn

      Affiliations

    • University of Texas Southwestern Medical Center, Dallas, TX, USA
    • Corresponding Author InformationCorresponding author. 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA. Tel.: +214-648-6430; fax: +214-648-0328.
    • ,
  • Husam Abed

      Affiliations

    • Henry Ford Health System, Detroit, MI, USA
    • ,
  • Vivian W. Sung

      Affiliations

    • Women and Infants Hospital of Rhode Island/Brown Medical School, Providence, RI, USA
    • ,
  • Kristen A. Matteson

      Affiliations

    • Women and Infants Hospital of Rhode Island/Brown Medical School, Providence, RI, USA
    • ,
  • Rebecca G. Rogers

      Affiliations

    • University of New Mexico Health Sciences Center, Albuquerque, NM, USA
    • ,
  • Michelle Y. Morrill

      Affiliations

    • Kaiser Permanente, San Francisco, CA, USA
    • ,
  • Matthew D. Barber

      Affiliations

    • Cleveland Clinic, Cleveland, OH, USA
    • ,
  • Joseph I. Schaffer

      Affiliations

    • University of Texas Southwestern Medical Center, Dallas, TX, USA
    • ,
  • Thomas L. Wheeler II

      Affiliations

    • University of South Carolina, Greenville, SC, USA
    • ,
  • Ethan M. Balk

      Affiliations

    • Tufts Medical Center, Boston, MA, USA
    • ,
  • Katrin Uhlig

      Affiliations

    • Tufts Medical Center, Boston, MA, USA
    • ,
  • Society of Gynecologic Surgeons—Systematic Review Group

,Accepted 13 March 2010.

References 

  1. Matteson KA, Boardman LA, Munro MG, Clark MA. Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril. 2009;92:205–216
  2. van Dongen H, van de Merwe AG, de Kroon CD, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2009;16:47–51
  3. Côté I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003;188:343–348
  4. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007;10:183–194
  5. Haynes P, Hodgson H, Anderson AB, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol. 1977;84:763–768
  6. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol. 2004;190:1216–1223
  7. Sung VW, Rogers RG, Schaffer JI, Balk EM, Uhlig K, Lau J, et al. Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol. 2008;112:1131–1142
  8. O'Flynn N, Britten N. Menorrhagia in general practice—disease or illness. Soc Sci Med. 2000;50:651–661
  9. O'Flynn N. Menstrual symptoms: the importance of social factors in women's experiences. Br J Gen Pract. 2006;56:950–957
  10. Santer M, Wyke S, Warner P. What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Womens Health. 2007;7:8
  11. Santer M, Wyke S, Warner P. Women's management of menstrual symptoms: findings from a postal survey and qualitative interviews. Soc Sci Med. 2008;66:276–288
  12. Warner P, Critchley HOD, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems: cross-sectional survey of symptoms, reasons for referral, and management. BMJ. 2001;323:24–28
  13. Garside R, Britten N, Stein K. The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs. 2008;63:550–562
  14. Clark TJ, Khan KS, Foon R, Pattison H, Bryan S, Gupta JK. Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;104:96–104
  15. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. GRADE Working Group. What is “quality of evidence” and why is it important to clinicians?. BMJ. 2008;336:995–998
  16. Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781–788
  17. Barnard K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J Womens Health. 2003;12:911–919
  18. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health. 1996;86:195–199
  19. Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003;188:343–348
  20. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734–739
  21. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964;16:244–248
  22. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?. BMJ. 1993;306:1440–1444
  23. Garratt AM, Ruta DA, Abdalla MI, Russell IT. SF 36 health survey questionnaire: II. Responsiveness to changes in health status in four common clinical conditions. Qual Health Care. 1994;3:186–192
  24. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation in internal reliability and face validity of the SF 36 questionnaire in women presenting with menorrhagia. Qual Health Care. 1996;5:9–12
  25. In:  Higgins JPT,  Green S editor. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009]. The Cochrane Collaboration; 2009;Available at www.cochrane-handbook.orgAccessed March 6, 2010
  26. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38
  27. Moher D, Schulz KF, Altman D for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987–1991
  28. Boutron I, Moher D, Altman D, Schulz K, Ravaud P for the CONSORT Group. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med. 2008;148:W-60–W-66
  29. Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Hum Reprod. 2007;22:635–643

 Funding/support: Funding of assistance by methodologic experts in systematic review and logistic support was provided by the Society of Gynecologic Surgeons.

PII: S0895-4356(10)00177-0

doi: 10.1016/j.jclinepi.2010.03.017

Journal of Clinical Epidemiology
Volume 64, Issue 3 , Pages 293-300 , March 2011

Article Tools

* Image Usage & Resolution